BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3101493)

  • 1. Clinical efficacy of desmopressin acetate for hemostatic control in patients with primary platelet disorders undergoing surgery.
    Kentro TB; Lottenberg R; Kitchens CS
    Am J Hematol; 1987 Feb; 24(2):215-9. PubMed ID: 3101493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I.
    Lethagen S; Harris AS; Nilsson IM
    Blut; 1990 Mar; 60(3):187-91. PubMed ID: 2107887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes.
    Ruggeri ZM; Mannucci PM; Lombardi R; Federici AB; Zimmerman TS
    Blood; 1982 Jun; 59(6):1272-8. PubMed ID: 6805532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.
    Holmberg L; Nilsson IM; Borge L; Gunnarsson M; Sjörin E
    N Engl J Med; 1983 Oct; 309(14):816-21. PubMed ID: 6412139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmopressin (dDAVP): a powerful general hemostatic agent?
    Drouet L; Scrobohaci ML; Boudaoud S; Vilain G
    Nouv Rev Fr Hematol (1978); 1989; 31(2):163-5. PubMed ID: 2528120
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].
    Fukui H; Takase T
    Rinsho Ketsueki; 1985 Jul; 26(7):1069-79. PubMed ID: 3932720
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmopressin: a nontransfusional hemostatic agent.
    Mannucci PM
    Annu Rev Med; 1990; 41():55-64. PubMed ID: 2184748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease.
    Warrier AI; Lusher JM
    J Pediatr; 1983 Feb; 102(2):228-33. PubMed ID: 6401806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDAVP (desmopressin) in the dental management of patients with mild or moderate hemophilia and von Willebrand's disease.
    Vierrou AM; de la Fuente B; Poole AE; Hoyer LW
    Pediatr Dent; 1985 Dec; 7(4):297-301. PubMed ID: 2938080
    [No Abstract]   [Full Text] [Related]  

  • 11. Response of patients with hemophilia A and von Willebrand disease to desmopressin (DDAVP).
    Santiago-Borrero PJ; Casanova R
    Bol Asoc Med P R; 1990 May; 82(5):207-10. PubMed ID: 2115785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No influence of blood group on the responsiveness to desmopressin in type I "platelet normal" von Willebrand's disease.
    Castaman G; Rodeghiero F
    Thromb Haemost; 1995 Mar; 73(3):551-2. PubMed ID: 7667843
    [No Abstract]   [Full Text] [Related]  

  • 13. [Desmopressin in hemophilia A and Von Willebrand's disease].
    Castro Cabezas M; de Graaf JC; Kraayenhagen RJ; Freen M; Poortman J; Hart HC
    Ned Tijdschr Geneeskd; 1991 Mar; 135(9):367-71. PubMed ID: 1901629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin.
    de la Fuente B; Kasper CK; Rickles FR; Hoyer LW
    Ann Intern Med; 1985 Jul; 103(1):6-14. PubMed ID: 3923887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years.
    Mannucci PM
    Blood; 1997 Oct; 90(7):2515-21. PubMed ID: 9326215
    [No Abstract]   [Full Text] [Related]  

  • 16. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin analogues. Their role in disorders of hemostasis.
    Mannuccio PM; Altieri D; Faioni E
    Ann N Y Acad Sci; 1987; 509():71-81. PubMed ID: 3122621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease.
    Rose EH; Aledort LM
    Ann Intern Med; 1991 Apr; 114(7):563-8. PubMed ID: 1900403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multimeric composition of factor VIII-related protein following DDAVP infusion in normal subjects and patients with hemophilia A and von Willebrand's disease].
    Takase T; Nishino M; Yasui M; Shima M; Yoshikawa N; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1985 Nov; 48(7):1571-8. PubMed ID: 3937410
    [No Abstract]   [Full Text] [Related]  

  • 20. New ways to boost factor VIII in hemophilia: DDAVP for mild hemophilia A, von Willebrand's.
    Marwick C
    JAMA; 1983 Jun; 249(24):3278-9. PubMed ID: 6406692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.